Fluticasone Furoate-Vilanterol Coupons & Prices

Looking for a Breo Ellipta coupon? Breo Ellipta (fluticasone furoate/vilanterol) is a once-daily maintenance inhaler that combines an inhaled corticosteroid with a long-acting beta2-agonist to help control asthma and COPD. It is a long-term controller, not a rescue inhaler. Enter your ZIP above to see today's cash price at pharmacies near you, and compare that with the manufacturer savings card and the available generic to find your lowest cost.

What is Breo Ellipta and how does it work?

Breo Ellipta pairs two medicines in one daily inhalation: fluticasone furoate, an inhaled corticosteroid (ICS) that reduces inflammation in the airways, and vilanterol, a long-acting beta2-agonist (LABA) that helps keep the airways open. Together they provide steady, around-the-clock control rather than quick relief.

It is approved for maintenance (long-term, once-daily) treatment of asthma in patients aged 5 years and older whose asthma is not adequately controlled on other controller medicines. It is also used for long-term maintenance treatment of airflow obstruction and to reduce flare-ups (exacerbations) in COPD, including chronic bronchitis and/or emphysema. Breo Ellipta is not a rescue inhaler and does not relieve sudden bronchospasm or an asthma attack; keep a separate fast-acting inhaler for that. This is general information, not medical advice, so talk with your provider about whether it fits your treatment plan.

Breo Ellipta cost: manufacturer savings card vs. Rx.com cash coupon

The "Breo Ellipta coupon" search results are usually split between the manufacturer's savings card and cash discount coupons. The maker offers a savings card and support resources; search for the Breo Ellipta savings card on the manufacturer's official website for current details. Manufacturer copay cards are generally limited to people with commercial (private) insurance and typically exclude Medicare, Medicaid, and other government plans; terms and eligibility vary, so check the official page for current details.

The Rx.com cash coupon works differently: it is a cash-price discount you can use if you are uninsured, on Medicare, or if the manufacturer card is declined at the counter. Enter your ZIP above to see today's price near you. A generic version also exists: fluticasone furoate/vilanterol. It is worth pricing both, but do not assume the generic is automatically cheaper. Today's only generic is an "authorized generic" (the same product relabeled), and its cash price is often close to, and sometimes higher than, the brand. Compare the generic fluticasone furoate/vilanterol and the brand side by side using your ZIP above, since savings vary by pharmacy and location, and ask your pharmacist which comes out lower for you.

Breo Ellipta alternatives and how it compares

If you and your provider are weighing options, several related inhalers treat asthma and/or COPD. The direct generic equivalent is fluticasone furoate/vilanterol. Other ICS/LABA combination inhalers include Advair Diskus (and its generic Wixela Inhub) and Symbicort.

Some patients need a third medicine. Trelegy Ellipta adds a long-acting muscarinic antagonist (LAMA) to the same fluticasone furoate/vilanterol combination for a triple-therapy option, while Anoro Ellipta is a LAMA/LABA combination without a steroid. Which is right depends on whether you are treating asthma or COPD and how well your symptoms are controlled, so this is a conversation to have with your prescriber.

Breo Ellipta safety and side effects

Because it contains a LABA, Breo Ellipta must never be used on its own for asthma without an inhaled corticosteroid, and it should not be used to treat sudden symptoms or an asthma attack. The LABA drug class historically carried a boxed warning about asthma-related death; however, large safety trials of ICS/LABA combinations, including fluticasone furoate/vilanterol, did not show a significant increase in serious asthma outcomes compared with an ICS alone, and the FDA removed that boxed warning from ICS/LABA combination labels in 2017.

Other possible risks include a higher chance of pneumonia in people with COPD, oral thrush (rinse your mouth after each dose), and corticosteroid effects such as adrenal suppression, reduced bone mineral density, slowed growth in children, and cataracts or glaucoma. Less common effects include paradoxical bronchospasm, allergic reactions, heart-rate or nervous-system effects from too much beta-agonist, low potassium, and high blood sugar. Use caution if you take strong CYP3A4 inhibitors. This is not a complete list; read the medication guide and talk with your provider or pharmacist about your personal risks.